Shape Memory Medical

Executive Summary

Shape Memory Medical is a private medical device company pioneering smart polymer-based embolization devices for vascular occlusion. Its proprietary shape memory polymer (SMP) technology dynamically conforms to vessel anatomy upon deployment, providing effective occlusion while promoting bioabsorption and natural healing. The devices target a range of indications across cardiovascular, peripheral, and neurovascular applications, offering potential advantages over conventional metal coils and liquid embolics, such as reduced chronic inflammation and improved vessel remodeling. Currently in the pre-clinical stage, the company has demonstrated promising preclinical data and is preparing to advance its lead product candidates toward first-in-human studies. With a robust IP portfolio and a differentiated technology platform, Shape Memory Medical is positioned to address significant unmet needs in embolotherapy, particularly in challenging anatomies where current devices fall short. The successful clinical translation of its SMP platform could establish a new standard of care in vascular occlusion, driving substantial commercial opportunities.

Upcoming Catalysts (preview)

• Q1 2027FDA IDE submission for first-in-human clinical trial50% success
• H2 2026Series C financing round to fund clinical development60% success
• 2027Strategic partnership with a major cardiovascular device manufacturer for co-development or distribution40% success